vs
Side-by-side financial comparison of Eos Energy Enterprises, Inc. (EOSE) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
Eos Energy Enterprises, Inc. is the larger business by last-quarter revenue ($58.0M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -207.7%, a 202.9% gap on every dollar of revenue. On growth, Eos Energy Enterprises, Inc. posted the faster year-over-year revenue change (699.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-75.2M).
Eos Energy Enterprises, Inc. is an energy storage solutions provider that designs, produces and deploys safe long-duration zinc-based battery systems. It serves utility, commercial, industrial and microgrid customers across North America, Europe and Asia, supporting grid stability and renewable energy integration.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
EOSE vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $47.7M |
| Net Profit | $-120.5M | $-2.3M |
| Gross Margin | -93.8% | — |
| Operating Margin | -140.1% | 14.3% |
| Net Margin | -207.7% | -4.8% |
| Revenue YoY | 699.6% | -47.3% |
| Net Profit YoY | 55.1% | -200.9% |
| EPS (diluted) | $-0.53 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.0M | $47.7M | ||
| Q3 25 | $30.5M | $122.1M | ||
| Q2 25 | $15.2M | $85.2M | ||
| Q1 25 | $10.5M | $41.1M | ||
| Q4 24 | $7.3M | $90.5M | ||
| Q3 24 | — | $91.6M | ||
| Q2 24 | — | $94.4M | ||
| Q1 24 | — | $74.9M |
| Q4 25 | $-120.5M | $-2.3M | ||
| Q3 25 | $-641.4M | $40.1M | ||
| Q2 25 | $-222.9M | $23.6M | ||
| Q1 25 | $15.1M | $-37.4M | ||
| Q4 24 | $-268.1M | $2.3M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $-860.0K | ||
| Q1 24 | — | $-4.2M |
| Q4 25 | -93.8% | — | ||
| Q3 25 | -111.2% | — | ||
| Q2 25 | -203.2% | — | ||
| Q1 25 | -234.7% | — | ||
| Q4 24 | -324.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -140.1% | 14.3% | ||
| Q3 25 | -200.6% | 61.8% | ||
| Q2 25 | -419.1% | 53.2% | ||
| Q1 25 | -506.2% | -70.7% | ||
| Q4 24 | -712.8% | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | — | 26.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | -207.7% | -4.8% | ||
| Q3 25 | -2102.1% | 32.8% | ||
| Q2 25 | -1463.2% | 27.7% | ||
| Q1 25 | 144.7% | -90.9% | ||
| Q4 24 | -3696.7% | 2.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | -0.9% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | $-0.53 | $0.01 | ||
| Q3 25 | $-4.91 | $0.23 | ||
| Q2 25 | $-1.05 | $0.14 | ||
| Q1 25 | $-0.20 | $-0.23 | ||
| Q4 24 | $-2.30 | $0.03 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $568.0M | $215.5M |
| Total DebtLower is stronger | $813.3M | — |
| Stockholders' EquityBook value | $-2.2B | $-261.8M |
| Total Assets | $885.2M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $568.0M | $215.5M | ||
| Q3 25 | $58.7M | $140.4M | ||
| Q2 25 | $120.2M | $92.9M | ||
| Q1 25 | $82.6M | $108.5M | ||
| Q4 24 | $74.3M | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | $813.3M | — | ||
| Q3 25 | $448.5M | $199.5M | ||
| Q2 25 | $445.3M | $199.3M | ||
| Q1 25 | $325.5M | $199.2M | ||
| Q4 24 | $316.9M | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $-2.2B | $-261.8M | ||
| Q3 25 | $-2.3B | $-264.2M | ||
| Q2 25 | $-1.1B | $-308.2M | ||
| Q1 25 | $-942.2M | $-334.1M | ||
| Q4 24 | $-1.1B | $-301.3M | ||
| Q3 24 | — | $-311.3M | ||
| Q2 24 | — | $-321.7M | ||
| Q1 24 | — | $-330.5M |
| Q4 25 | $885.2M | $396.9M | ||
| Q3 25 | $328.2M | $396.1M | ||
| Q2 25 | $361.0M | $342.9M | ||
| Q1 25 | $263.3M | $327.2M | ||
| Q4 24 | $260.3M | $350.9M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $395.6M | ||
| Q1 24 | — | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.3M | $74.6M |
| Free Cash FlowOCF − Capex | $-75.2M | $74.6M |
| FCF MarginFCF / Revenue | -129.7% | 156.3% |
| Capex IntensityCapex / Revenue | 43.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-265.0M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.3M | $74.6M | ||
| Q3 25 | $-65.9M | $47.6M | ||
| Q2 25 | $-66.1M | $-15.1M | ||
| Q1 25 | $-28.9M | $20.0M | ||
| Q4 24 | $-42.7M | $15.2M | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $45.0M |
| Q4 25 | $-75.2M | $74.6M | ||
| Q3 25 | $-82.7M | $47.6M | ||
| Q2 25 | $-73.2M | $-15.1M | ||
| Q1 25 | $-33.8M | $19.9M | ||
| Q4 24 | $-55.8M | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | -129.7% | 156.3% | ||
| Q3 25 | -271.1% | 39.0% | ||
| Q2 25 | -480.2% | -17.7% | ||
| Q1 25 | -323.6% | 48.4% | ||
| Q4 24 | -769.1% | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | 43.1% | 0.0% | ||
| Q3 25 | 55.2% | 0.0% | ||
| Q2 25 | 46.2% | 0.0% | ||
| Q1 25 | 47.0% | 0.1% | ||
| Q4 24 | 180.6% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | -1.91× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
